SCHEMBL16112382

SCHEMBL16112382

CCCCOC(=O)N1CCN(c2ccc(-c3cnc4c(Br)cnn4c3)cc2Cl)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK4 O00444 1/20 0.43
AURKA O14965 1/20 0.43
DYRK3 O43781 1/20 0.43
MAP4K4 O95819 1/20 0.43
NTRK1 P04629 1/20 0.43
INSR P06213 1/20 0.43
CDK1 P06493 1/20 0.43
FGFR1 P11362 1/20 0.43
FLT1 P17948 1/20 0.43
CDK2 P24941 1/20 0.43
MARK3 P27448 1/20 0.43
FLT4 P35916 1/20 0.43
KDR P35968 1/20 0.43
FLT3 P36888 1/20 0.43
CLK2 P49760 1/20 0.43
GSK3A P49840 1/20 0.43
GSK3B P49841 1/20 0.43
IRAK1 P51617 1/20 0.43
CSNK2A1 P68400 1/20 0.43
CSNK1G2 P78368 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16112298 0.91 MAPT (0.44) PLK4AURKADYRK3MAP4K4NTRK1
SCHEMBL16112722 0.89 RET (0.44) PLK4AURKADYRK3MAP4K4NTRK1
SCHEMBL16111712 0.85 RET (0.57) PLK4AURKADYRK3MAP4K4NTRK1
SCHEMBL16112667 0.80 CYP4F2 (0.54) PLK4AURKADYRK3MAP4K4NTRK1
SCHEMBL17531629 0.76 PRKAB2 (0.52) PLK4AURKADYRK3MAP4K4NTRK1
SCHEMBL16112600 0.76 PLK4 (0.47) PLK4AURKADYRK3MAP4K4NTRK1
SCHEMBL16134907 0.76 RET (0.56) PLK4AURKADYRK3MAP4K4NTRK1
SCHEMBL16112583 0.74 RET (0.57) RET
SCHEMBL20856536 0.72 MAPT (0.63) MAPTALDH1A1GAAIDEHRH2
SCHEMBL16026085 0.72 RET (0.58) PLK4AURKADYRK3MAP4K4NTRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2970311-A2 BMP INHIBITORS AND METHODS OF USE THEREOF The Brigham and Women's Hospital, Inc. (US) 2016-01-20 EP disclosed
WO-2014160203-A2 BMP INHIBITORS AND METHODS OF USE THEREOF THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 2014-10-02 WO disclosed